Abeona Therapeutics (FRA:PCJ) Ending Cash Position : €16.46 Mil (As of Mar. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Abeona Therapeutics Ending Cash Position?

Abeona Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 was €16.46 Mil.

Abeona Therapeutics's quarterly Ending Cash Position increased from Sep. 2023 (€4.73 Mil) to Dec. 2023 (€13.58 Mil) and increased from Dec. 2023 (€13.58 Mil) to Mar. 2024 (€16.46 Mil).

Abeona Therapeutics's annual Ending Cash Position declined from Dec. 2021 (€34.36 Mil) to Dec. 2022 (€13.74 Mil) and declined from Dec. 2022 (€13.74 Mil) to Dec. 2023 (€13.58 Mil).

Abeona Therapeutics Ending Cash Position Historical Data

The historical data trend for Abeona Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abeona Therapeutics Ending Cash Position Chart

Abeona Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

117.33

11.16

34.36

13.74

13.58

Abeona Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															4.69	6.06	4.73	13.58	16.46

Abeona Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Abeona Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	13.347	+	0.23500000000001
	=	13.58

Abeona Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	13.626	+	2.838
	=	16.46

Abeona Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Abeona Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Abeona Therapeutics (FRA:PCJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abeona Therapeutics Inc (FRA:PCJ) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

ABEO:USA

Address

1330 Avenue of the Americas, 33rd Floor, New York, NY, USA, 10019

Website

https://www.abeonatherapeutics.com

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.

Abeona Therapeutics (FRA:PCJ) Headlines

No Headlines